Product information and disease descriptionProduct description
Phase of product development
12 evidence topics · 9 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionProduct description
12 evidence topics · 9 sources